(Q35005947)

5 August 2017

1 reference

title

Multiple pathways to tumor immunity and concomitant autoimmunity (English)

1 reference

5 August 2017

Jedd D Wolchok

1 reference

5 August 2017

Mary Jo Turk

1 reference

5 August 2017

José A Guevara-Patino

series ordinal

1 reference

5 August 2017

Stacie M Goldberg

series ordinal

1 reference

5 August 2017

Alan N Houghton

series ordinal

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

published in

Immunological Reviews

1 reference

5 August 2017

volume

188

1 reference

5 August 2017

page(s)

122-135

1 reference

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Fc receptors are required in passive and active immunity to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Heteroclitic immunization induces tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Toll meets bacterial CpG-DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

Cancer antigens: immune recognition of self and altered self

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Serological survey of normal humans for natural antibody to cell surface antigens of melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Tumor immunity and autoimmunity induced by immunization with homologous DNA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

Active specific immunotherapy in malignant melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-065X.2002.18811.X

7 January 2021

10.1034/J.1600-065X.2002.18811.X

Identifiers

DOI

1 reference

5 August 2017

1 reference